CREDIT SUISSE AG/ - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 134 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$2,367,887
-19.5%
51,487
+0.6%
0.00%
-33.3%
Q2 2023$2,941,602
+35.3%
51,185
-11.7%
0.00%
+50.0%
Q1 2023$2,173,350
+39.2%
57,956
+4.0%
0.00%0.0%
Q4 2022$1,560,994
+42.7%
55,710
+43.1%
0.00%
+100.0%
Q3 2022$1,094,000
-11.1%
38,929
+10.0%
0.00%0.0%
Q2 2022$1,231,000
-17.4%
35,398
-14.8%
0.00%0.0%
Q1 2022$1,490,000
+77.4%
41,535
+15.2%
0.00%
Q4 2021$840,000
+27.5%
36,070
+4.0%
0.00%
Q3 2021$659,000
-16.3%
34,667
-11.3%
0.00%
Q2 2021$787,000
+3.6%
39,074
-5.8%
0.00%
Q1 2021$760,000
-25.3%
41,501
-17.8%
0.00%
Q4 2020$1,017,000
+41.4%
50,511
+31.5%
0.00%
Q3 2020$719,000
-20.2%
38,402
-4.3%
0.00%
-100.0%
Q2 2020$901,000
+77.0%
40,119
+16.9%
0.00%
Q1 2020$509,000
-31.1%
34,315
-10.5%
0.00%
-100.0%
Q4 2019$739,000
-4.3%
38,342
-1.6%
0.00%0.0%
Q3 2019$772,000
+23.1%
38,978
+31.4%
0.00%0.0%
Q2 2019$627,000
-19.6%
29,672
-22.2%
0.00%0.0%
Q1 2019$780,000
-18.2%
38,124
-20.4%
0.00%0.0%
Q4 2018$953,000
+40.8%
47,883
+36.3%
0.00%0.0%
Q3 2018$677,000
-7.1%
35,131
-26.6%
0.00%0.0%
Q2 2018$729,000
-23.9%
47,844
-6.4%
0.00%0.0%
Q1 2018$958,000
+1.3%
51,108
+4.0%
0.00%0.0%
Q4 2017$946,000
+14.3%
49,131
+6.1%
0.00%0.0%
Q3 2017$828,000
+104.4%
46,295
+104.0%
0.00%
Q2 2017$405,000
-16.5%
22,697
-32.1%
0.00%
Q1 2017$485,000
-65.2%
33,421
-55.8%
0.00%
-100.0%
Q4 2016$1,394,000
-36.3%
75,655
-34.4%
0.00%
-50.0%
Q3 2016$2,187,000
+102.7%
115,248
+72.2%
0.00%
+100.0%
Q2 2016$1,079,000
+188.5%
66,912
+114.8%
0.00%
Q1 2016$374,000
-4.3%
31,158
+13.7%
0.00%
Q4 2015$391,000
-32.1%
27,403
-44.4%
0.00%
-100.0%
Q3 2015$576,000
-54.2%
49,283
-31.2%
0.00%0.0%
Q2 2015$1,259,000
+72.0%
71,625
+46.4%
0.00%0.0%
Q1 2015$732,000
+255.3%
48,916
+174.7%
0.00%
Q4 2014$206,00017,8060.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2019
NameSharesValueWeighting ↓
EAM Investors, LLC 173,018$3,187,0000.42%
GLOBEFLEX CAPITAL L P 50,686$934,0000.23%
KALMAR INVESTMENTS INC /DE/ 240,648$4,433,0000.23%
ESSEX INVESTMENT MANAGEMENT CO LLC 63,661$1,173,0000.19%
OBERWEIS ASSET MANAGEMENT INC/ 27,200$501,0000.15%
Invictus RG 11,950$220,0000.15%
ACADIAN ASSET MANAGEMENT LLC 1,502,151$27,668,0000.13%
FOX RUN MANAGEMENT, L.L.C. 12,600$232,0000.12%
Piermont Capital Management Inc. 26,153$482,0000.11%
FEDERATED HERMES, INC. 1,344,684$24,769,0000.07%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders